Alcidion Group Limited · ASX:ALC
Alcidion — H1 FY2021 Earnings Presentation
9 slides from Alcidion's earnings presentation, Feb 25, 2021
Slide 1: Investor Presentation
COMMERCIAL IN CONFIDENCE Investor Presentation Half Year Results - H1 FY2021 Kate Quirke, Group Managing Director 25 February 2021 1
Slide 2: H1 FY2021 Highlights
H1 FY2021 Highlights • H1 revenue of $11.1M – up 36% on pcp (H1 FY2020) • Gross profit of $9.8M (88.1% gross profit margin), up from $7.1M (87.4%) pcp • $17.4M contracted revenue added in H1, one of Alcidion’s strongest sales periods to date • Contracted revenue to be recognised in FY2021 increased
Slide 3: H1 Financial Snapshot
H1 Financial Snapshot $11.1M $9.8M 88.1% REVENUE GROSS PROFIT GROSS PROFIT MARGIN 36% UP ON PCP 37% UP ON PCP UP FROM 87.4% PCP ($0.9M) $10.8M $12.5M EBITDA LOSS CASH RECEIPTS CASH AT 47% IMPROVEMENT 17% UP ON PCP 31 DECEMBER 2020 ON PCP 3
Slide 4: Profit & Loss
Profit & Loss Key Comments Profit & Loss (A$'000) H1 FY21 H1 FY20 % Change • $11.1M revenue in H1 FY2021, 36% increase on pcp Recurring 6,344 4,549 39% Non-recurring 4,762 3,616 32% – c.60% of non-recurring revenue relates to Product implementation Total Revenue 11,106 8,165 36% services which are r
Slide 5: Milestone $11.3M contract with South Tees NHS Trust
Milestone $11.3M contract with South Tees NHS Trust • Largest Miya Precision contract with TCV1 of + A$11.3M over five years $9.3M – Miya Precision will be used across 1,000 • Our flagship product suite • Medication management initial beds, enabling digitalisation of patient care solution contract •
Slide 6: Important ANZ Miya Precision contracts
Important ANZ Miya Precision contracts Initial 12-month contracts signed with an opportunity to expand timelines and scope • Two contracts with a Total Contract Value (TCV) of • Initial 12-month with a TCV of $0.6M $0.7M over 12 months • Option to extend for further 12 months • Includes continued us
Slide 7: Further H1 Contracts & Extensions
Further H1 Contracts & Extensions UK Contracts & Extensions ANZ Contracts & Extensions • 5-year, $1.5M contract with NHS Lanarkshire to • NT Health extension for program management services implement Miya Observations & Assessments (Patientrack) • New integration services contracts with ACT Health •
Slide 8: Outlook
Outlook Alcidion advantageously positioned for H2 FY2021, with the Health IT sales environment progressively returning to pre COVID-19 levels • On track to surpass FY2020 revenue, with contracted revenue for FY2021 already 17% higher and six months of the year remaining • From FY2022 to FY2026, furt
Slide 9: Questions
Questions Please enter your question using the Zoom Q&A function